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INTRODUCTION
Diabetic peripheral neuropathy (DPN) is one of the most common microvascular complications of diabetes. Depending on the methods used to diagnose DPN, it is generally held that at least 50% of all diabetic patients will develop neuropathy [1] [2] [3] . However, the precise pathogenesis of DPN remains unclear and is known to involve multiple pathways, including the polyol, advanced glycation end-products, protein kinase C and hexosamine pathway. Recent evidence indicates that all of the four pathways result from increased levels of cellular reactive oxygen species (ROS), which impairs nerve function, resulting in apoptosis and subsequent neuronal injury [4] [5] [6] [7] [8] [9] [10] . Apparently, inhibition of ROS may restore metabolic and vascular imbalances and block the progression of neuropathy [6, 11] .
Radix puerariae (kudzu root) is a well-known traditional Chinese medicinal herb, which has been widely used for treating various diseases including cardiovascular and brain disorders [12] . Puerarin (daidzein-8-C-glucoside) is the major isoflavonoid derived from Radix puerariae and has been proven to be effective in treating heart diseases [13] . Recent evidence indicates that the protective mechanisms of puerarin are at least partly related to its function in increasing superoxide dismutase activity [13] [14] . However, whether puerarin can benefit patients with DPN has not been explored.
Schwann cells play a critical role in maintaining peripheral nerve function and are susceptible to hyperglycemic toxicity because they take up glucose through the insulin-independent glucose transporter [15] [16] .
Schwann cells may be a natural target for the treatment of DPN because defects in Schwann cells are reversible [17] [18] . Hyperglycemia has been proposed to be a potent initiator of apoptosis, and Schwann cell apoptosis has been detected in diabetic models [10, [19] [20] [21] .
In fact, oxidative stress reduces mitochondrial transmembrane potential (ΔΨm) and triggers apoptosis by activating caspase-9 and -3. The apoptotic process is mainly regulated by Bcl-2 family proteins.
Little is known about the effect of puerarin on high glucose-induced oxidative stress and the downstream signaling that leads to apoptosis. This study aimed to examine the impact of high glucose on Schwann cell apoptosis and determine if puerarin treatment could modulate the effect of high glucose on Schwann cell apoptotic cell death in vitro.
RESULTS

Puerarin inhibits high glucose-induced ROS generation in Schwann cells in vitro
The levels of intracellular ROS in different groups of cells were determined by flow cytometry ( Figures 1A and B) .
In comparison with the control, the relative levels of ROS in the high glucose group increased by 2.26 folds (P < 0.01). The relative levels of intracellular ROS in puerarin-treated cells were reduced by 13.9% (P < 0.05), 26.9% (P < 0.01) and 39.5% (P < 0.01), at 1, 10 and 100 μM, respectively. It is quite clear that puerarin inhibited the high glucose-induced overproduction of ROS in Schwann cells in a dose-dependent manner from 1 to 100 μM. Interestingly, no significant difference in the relative levels of intracellular ROS was observed between mannitol-treated and control cells (P > 0.05).
Puerarin mitigated high glucose-induced mitochondrial depolarization and DNA damage in Schwann cells
As shown in Figures 1C and D , the values of ΔΨm in the high glucose group significantly decreased (P < 0.01).
However, values of ΔΨm in puerarin-treated cells were significantly increased in a dose-dependent manner. 8-hydroxy-2-deoxyguanosine (8-OHdG) is a sensitive and specific marker of oxidative DNA damage. The experimental data showed that concentrations of 8-OHdG in the high glucose group significantly increased when compared with the control (P < 0.01; Figure 2 ). Furthermore, the high glucose groups treated with high and medium concentrations of puerarin decreased 8-OHdG levels (P < 0.05, P < 0.01). There was no significant difference in the values of ΔΨm and concentrations of 8-OHdG between the control and mannitol-treated group (P > 0.05). Therefore, puerarin inhibited the high glucose-related oxidative stressmediated loss of ΔΨm and DNA damage in Schwann cells.
Puerarin inhibits high glucose-induced apoptosis of Schwann cells
Apoptotic cells were identified by a black-brown signal following 3,3'-diaminobenzidine staining ( Figure 3A ). As shown in Figure 3B , quantitative analysis indicated that the percentage of apoptotic cells in the high glucose group was significantly higher than that in control cells (P < 0.01). While treatment with mannitol did not change the apoptotic rate of Schwann cells, treatment with puerarin did (P < 0.01). Therefore, it can be concluded that puerarin inhibited high glucose-induced apoptosis of Schwann cells in vitro.
Effects of puerarin on high glucose-related bax and bcl-2 expression
To understand the mechanisms underlying the role of puerarin in high glucose-related Schwann cell apoptosis, the relative levels of anti-apoptotic bcl-2 and proapoptotic bax mRNA transcripts in different groups of cells were determined by quantitative reverse transcription-PCR ( Figures 4A and B) . Quantitative analysis indicated that Schwann cells in high glucose conditions significantly enhanced the transcription of the bax gene, but reduced the transcription of the bcl-2 gene when compared with that of the control (P < 0.01). Treatment with mannitol did not change the expression of these genes; however, treatment with puerarin significantly attenuated the effect of high glucose on the expression of these genes, particularly in cells treated with 100 and 10 μM of puerarin (P < 0.05, P < 0.01). As shown in Figures 4C-E, western blot analysis revealed that Schwann cells in high glucose conditions significantly enhanced the expression of bax, but reduced the expression of bcl-2 when compared with the control (P < 0.01). Expression of bax in puerarin-treated cells was significantly reduced while the relative levels of bcl-2 in these groups of cells were significantly elevated when compared with that of the high glucose group (P < 0.01).
There was no significant difference in protein expression between the control and osmotic control (P > 0.05). To further characterize hyperglycemia-related apoptosis, relative levels of cleaved caspase-9 and -3 were determined by western blot analysis ( Figure 5A ). The quantitative analysis revealed that relative levels of cleaved caspase-9 and-3 in the high glucose group of cells were significantly higher than those of the control (P < 0.01; Figures 5B and C) . Furthermore, there was no significant difference in the levels of these proteins between the mannitol-treated and untreated controls (P > 0.05). However, treatment with puerarin significantly inhibited caspase-9 and-3 activation and their inhibitory effect appeared to be dose-dependent in the high glucose group. These data clearly demonstrated that puerarin inhibited high glucose-related caspase activation in Schwann cells.
Effect of puerarin on caspase activation
DISCUSSION
Hyperglycemia, which occurs under diabetic conditions, is widely recognized as a major etiological factor causing diabetic complications [22] . For nervous cells, previous studies have shown that hyperglycemic injury can occur when glucose levels are higher than 35 mM. However, lower concentrations of glucose have been shown to induce neuronal death in culture [8] . Moreover, 30 to 150 mM glucose has been used in individual experiments to produce hyperglycemic injury in Schwann cells, which is higher than human serum glucose concentrations [21, [23] [24] [25] [26] . However, the reason why these hyperglycemic concentrations lead to high levels of Schwann cell injury (in vitro) remains unclear. In this study, we used 50 mM glucose as a high dose according to the previous studies [27] [28] .
Increasing evidence indicates that mitochondria are both the source and target of ROS [29] . As hyperglycemic cells metabolize more glucose, increased turnover of mitochondrial energy-generating complexes occur, increasing the production of free radicals [30] .
Hyperglycemia can induce oxidative stress in mitochondria, which in turn activates four known pathways: the polyol, hexosamine, protein kinase C and advanced glycation end-products pathways [5] . Schwann cells are susceptible to oxidative stress because of their large population of mitochondria. ROS, generated by high glucose, leads to nervous system damage and Schwann cells are specific targets of oxidative injury [4, 21] .
Hyperglycemia-related stress results in apoptotic cell death and ROS, which is also a well-known initiator of apoptosis in many cell types [31] [32] [33] . This study examined the effect of constant high glucose on ROS production and apoptosis of Schwann cells in vitro. The present study found that high glucose produced higher levels of ROS and DNA-associated 8-OHdG and promoted more significant changes in ΔΨm than the control. In agreement with previous studies [34] [35] [36] , this study confirmed that stable high glucose led to an increase in apoptosis as a result of oxidative stress generation. This suggests a cause-effect relationship between mitochondrial oxidative stress and Schwann cell apoptosis.
According to traditional Chinese medicine, Radix puerariae is a popular herb, which has been widely and successfully used for many years. Puerarin (daidzein-8-C-glucoside) is a major isoflavonoid derived from Radix puerariae. It was reported to possess many biological activities [13] [14] . Nevertheless, there is insufficient information on its protective properties in DPN. The present study revealed that puerarin significantly inhibited high glucose-stimulated ROS production, 8-OHdG formation, loss of ΔΨm and apoptosis in Schwann cells in a dose-dependent manner. These data indicated that treatment with puerarin can reduce oxidative stress-related apoptosis and may be beneficial for patients with DPN.
Apoptosis involves a cascade of intracellular events, the process of which could not be ceased once activated [37] [38] . We characterized the molecular pathways through which high glucose triggered Schwann cell apoptosis. We found that high glucose significantly upregulated bax expression, but downregulated bcl-2 expression in Schwann cells. Meanwhile, high glucose promoted the activation of caspase-9 and -3. More importantly, puerarin inhibited high glucose-upregulated bax expression, but antagonized high glucose-downregulated bcl-2 expression in Schwann cells. In addition, puerarin inhibited caspase-9 and -3 cleavage in a dose-dependent manner. These changes were accompanied by decreasing Schwann cell apoptosis. Given that puerarin can reduce Schwann cell apoptosis, the protective effect of puerarin on apoptotic pathway-related events were mediated by inhibiting oxidative injury in Schwann cells. Therefore, it is possible that puerarin may be valuable for the treatment of DPN.
In this study, to exclude the role of osmolarity on apoptosis, we used mannitol as an osmotic control. Data showed that the neurotoxicity of glucose was not related to osmolarity. Instead, it is a direct effect of glucose on the cell.In summary, high glucose induced the overproduction of ROS and mitochondrial dysfunction, which triggered a high rate of Schwann cell apoptosis. Furthermore, puerarin inhibited high glucose-induced oxidative stress and mitochondrial dysfunctionassociated Schwann cell apoptosis. Although further work is still needed, our findings provide remarkable evidence that puerarin exhibits a protective effect on Schwann cells exposed to high glucose.
MATERIALS AND METHODS
Design
This is a cytological, comparative, observational study. [39] .
Time and setting
Methods
Preparation of puerarin
Puerarin was purchased from Phytomarker Ltd (Tianjin, China) and the purity was determined to be 98% by highperformance liquid chromatography. A stock solution of puerarin (1 mM) was dissolved in deionized water and stored at -20 °C.
Cell culture and treatment
Schwann cells were obtained from the sciatic nerves of new-born Sprague-Dawley rats under aseptic conditions, as previously described [27] . Briefly, sciatic nerves were dissected out, placed into D-Hanks medium and minced into roughly 1 mm × 1 mm explants. The nerve explants were cultured in Dulbecco's modified Eagle's medium (Gibco, Grand Island, NY, USA) supplemented with 20% (v/v) heat-inactivated fetal bovine serum (Hyclone, Logan, UT, USA), 100 U/mL penicillin (Gibco), 100 μg/mL streptomycin (Gibco), 2 mM L-glutamine, 1 mM sodium pyruvate and 12.5 mM N-(2-hydroxylethyl)-piperazine-N-2-ethane sulfonic acid (Sigma, St Louis, MO, USA) at 37°C in a humidified 5% CO 2 incubator. The cultured Schwann cells were identified by their morphology and immunohistochemistry using anti-S-100 protein (1:100 dilution; Boster, Wuhan, China). Only the second and third passages of Schwann cells with a purity of 95% were used in this study to avoid age-dependent cellular modifications ( Figure 6 ). Schwann cells at 2 × 10 5 /mL were cultured on poly-lysine-coated coverslips in 6-well plates. When they reached 70% confluency, cells were starved overnight and treated in duplicate with different conditions.
Measurement of ROS
Intracellular ROS generation was detected using the Becton Dickinson FACS system and dihydroethidine (Jiamay Biotech, Beijing, China) [28] . Dihydroethidine is mainly oxidized by superoxide anions and is the practice probe used to detect cellular ROS levels. In brief, cells at 2 × 10 6 /mL in different culture conditions were harvested and treated with 10 μM of dihydroethidine at 37°C for 60 minutes in the dark. Results of fluorescent intensity from 10 000 events were analyzed in each sample and corrected for auto-fluorescence from unlabeled cells. ROS values were calculated as relative levels of the experiment to unlabeled control cells.
Measurement of ΔΨm
Schwann cells in different culture conditions were harvested and Ψm of those cells were characterized using the lipophilic cationic probe 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazol-carbocyanine iodine assay (Jiamay Biotech). 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazol-carbocyanine iodine is a lipophilic cationic fluorescent dye that exists as an aggregate at very negative membrane potentials (ΔΨm < -100 mV, red fluorescence). As a ΔΨm > -100 mV, 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazol-carbocyanine iodine exists as a monomer (green fluorescence) [40] . In brief, harvested cells at 2 × 10 6 /mL were stained with 3 μM of 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodine at 37°C for 60 minutes in the dark. A minimum of 10 000 cells per sample were analyzed. The green fluorescence from the 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazol-carbocyanine iodine monomer with a 530-nm excitation and the red fluorescence from the aggregated form of 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazol-carbocyanine iodine with a 590-nm emission were visualized simultaneously. The results were calculated as the ratio of red/green fluorescence.
Detection of 8-OHdG
Schwann cells in different culture conditions were harvested and their DNA was isolated using a genomic DNA extraction kit (Generay Biotechnology, Shanghai, China). The amount of 8-OHdG was determined using the 8-OHdG enzyme-linked immunosorbent assay kit, a competitive enzyme-linked immunosorbent assay (StressMarq Biosciences, Victoria, Canada) according to the manufacturer's instructions [40] . The levels of 8-OHdG in each sample were calculated according to the standard curve.
Determination of apoptotic cells
Apoptotic cells were detected by TUNEL using the in situ cell death detection kit (Roche, Mannheim, Germany) according to the manufacturer's instructions [40] . Apoptotic cells were examined under a light microscope (Olympus, in Shinjuku, Tokyo, Japan) and representative photomicrographs of TUNEL staining in Schwann cells were obtained. At least 500 cells from each group were examined in a blinded manner.
Quantitative real-time reverse transcription-PCR
Total RNA was extracted from Schwann cells using Trizol (Invitrogen, Grand Island, NY, USA). The RNA (1 μg) was reversely transcribed into cDNA using the cDNA synthesis kit (Invitrogen) according to the manufacturer's protocol. The relative levels of each gene mRNA transcripts to control GAPDH were determined using the Eva Green (Biotium, Hayward, CA, USA) dye and specific primers. The sequences of the primers are shown as follows: The PCR reactions were performed in triplicate at 95°C for 2 minutes and subjected to 40 cycles of 95°C for 20 seconds, 58°C for 20 seconds, and 72°C for 25 seconds. The relative levels of each gene mRNA transcript to GAPDH were analyzed by 2 -ΔΔCt method [40] .
Western blot analysis
The relative levels of target molecule expression were determined by western blot analysis [40] . After determining the concentration of total protein, cell lysates (50 g/lane) were separated by SDS-polyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride membranes (Millipore, Billerica, MA, USA). Subsequently, the membranes were blocked with 5% (w/v) fat-free milk and incubated with either a 1:200 dilution of rabbit-anti-bcl-2, rabbit-anti-bax, rabbit-anti-β-actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA), or a 1:800 dilution of rabbit-anti-cleaved-caspase-3 and rabbit-anti-cleaved-caspase-9 (Cell Signaling Technology, Beverly, CA, USA). The bound antibodies were detected with a 1:5 000 dilution of goat-anti-rabbit IgG (Santa Cruz Biotechnology) and visualized by enhanced chemiluminescence detection reagents (Applygen Technologies, Beijing, China). The relative levels of each protein to β-actin were determined by densitometry analysis using Image Tool software (Image Tool for Windows, USA).
Statistical analysis
All data were expressed as the mean ± SEM. The difference among groups was analyzed by one-way analysis of variance using SPSS 13.0 software (SPSS, Chicago, IL, USA). A value of P < 0.05 was considered statistically significant. 
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